Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-019708

KYNTRA BIO, INC. · KYNB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Rory B Riggs
Director
Period of report
Mar 12, 2018
Accepted (ET)
Mar 14, 2018 · 8:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 12, 2018S19,693$54.98D391,602D
Common StockF2Mar 13, 2018S5,402$53.07D386,200D
Common StockF3Mar 13, 2018S4,382$54.90D381,818D
Common StockF4Mar 13, 2018S2,618$55.19D379,200D
Common StockF5holding———605,713ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses